Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Haemonetics Corp. buy Robert W. Baird

Start price
€62.50
26.06.25 / 50%
Target price
€74.44
26.06.26
Performance (%)
12.00%
Price
€72.00
11.12.25
Summary
This prediction is currently active. The prediction currently has a performance of 12.00%. This prediction currently runs until 26.06.26. The prediction end date can be changed by Robert_W__Baird at any time. Robert_W__Baird has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Haemonetics Corp. 0.000% 0.000%
iShares Core DAX® 0.734% 1.458%
iShares Nasdaq 100 -2.686% -0.146%
iShares Nikkei 225® -2.261% -2.729%
iShares S&P 500 -1.346% 0.467%

Comments by Robert_W__Baird for this prediction

In the thread Haemonetics Corp. diskutieren
Prediction Buy
Perf. (%) 12.00%
Target price 74.437
Change
Ends at 26.06.26

Haemonetics Corporation (NYSE: HAE) is now covered by analysts at Robert W. Baird. They set an "outperform" rating and a $87.00 price target on the stock.
Ratings data for HAE provided by MarketBeat